Related Experiment Video
Updated: Oct 24, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Validation and Reliability of the Turkish Version of the Inflammatory Bowel Disease-Disk in Patients with
Tugba Tolu1, Yasemin Kaldirim Armutcuoglu1, Tuba Yilmaz Yildirim1
1Department of Gastroenterology, Marmara University School of Medicine, İstanbul, Türkiye.
Background/Aims:
The inflammatory bowel disease-disk (IBD-Disk) is a visual patient reported outcome measure designed to assess disease-related burden in patients with IBD. This study aimed to translate and culturally adapt the IBD-Disk into Turkish and evaluate its psychometric performance and association with clinical disease activity.
Materials And Methods:
This prospective validation study was conducted between July 2025 and April 2026 at a tertiary referral center. The IBD-Disk was translated using a standardized forward-backward methodology and pilot tested. Assessments were performed at baseline, after 2 weeks in a clinically stable subgroup to evaluate test-retest reliability, and at 6-month follow-up. Disease activity was assessed using the Harvey-Bradshaw Index for Crohn's disease (CD), partial Mayo score for ulcerative colitis (UC), and the Physician Global Assessment (PGA).
Results:
A total of 202 patients were included, comprising 114 with CD and 88 with UC; 136 patients had complete longitudinal data. The Turkish IBD-Disk demonstrated high internal consistency (Cronbach's α = 0.884) and moderate test-retest reliability (intraclass correlation coefficient = 0.68; 95% CI, 0.16-0.90). IBD-Disk scores were moderately correlated with disease activity indices in patients with CD and UC (ρ = 0.525 and ρ = 0.503, respectively; both P < .001) and differed significantly across PGA categories (P < .001). The instrument demonstrated moderate accuracy for detecting active disease (area under the curve = 0.72; 95% CI, 0.65-0.79), with a preliminary receiver operating characteristic-derived cutoff of ≥27.5 (sensitivity 76.1%, specificity 60.5%). Scores decreased significantly among patients with clinical improvement at follow-up (P < .001).
Conclusion:
The Turkish version of the IBD-Disk demonstrated acceptable validity and reliability for assessing patient-perceived disease burden in patients with IBD and demonstrated responsiveness to clinical improvement.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
